Table 1.
Figure | Experiment | N | Groups | AI (%) | p value | |
---|---|---|---|---|---|---|
2A | HA vs. LA | 10 | HA | 60 ± 3.6 | ||
10 | LA | 75 ± 4.5 | *0.0193 | |||
2B | intra-insular Propanolol dose response curve (HA) | 12 | Veh | 67 ± 5.3 | ||
10 | 1 μg | 56 ± 4.2 | ||||
10 | 5 μg | 48 ± 4.1 | *0.0470 | |||
10 | 10 μg | 59 ± 4.5 | ||||
2C | Intra-insular Noradrenaline dose response curve (LA) | 15 | Veh | 58 ± 2.6 | ||
11 | 1 μg | 69 ± 2.6 | **0.0082 | |||
11 | 10 μg | 60 ± 1.9 | ||||
13 | 100 μg | 62 ± 2.7 | ||||
2D | Inhibition of oral Propanolol by intra-insular Noradrenline (HA) | 11 | Veh prop + Veh NA | 64 ± 2.1 | ||
10 | Prop + Veh NA | 52 ± 3.7 | *0.0470 | |||
7 | Prop + NA | 58 ± 5.2 | ||||
3A | Systemic Epinephrine dose response curve (LA) | 9 | Veh | 64 ± 2.8 | ||
10 | 0.001 mg | 62 ± 4.3 | ||||
9 | 0.01 mg | 82 ± 3.3 | ||||
10 | 0.1 mg | 86 ± 3.8 | ***0.0002 | |||
10 | 1 mg | 69 ± 5.6 | ||||
3B | Epinephrine (0.1 mg) + intra-insular Propanolol dose response curve (LA) | 8 | Epi + Veh prop | 70 ± 3.8 | ||
7 | Epi + Prop 1 μg | 48 ± 2.7 | **0.0022 | |||
8 | Epi + Prop 5 μg | 54 ± 2.7 | ||||
7 | Epi + Prop 10 μg | 55 ± 5.5 |
Depicted from left to right are: the Figure panel where experiment is shown (Figure), a description of the experiment (Experiment), the number of animals per group (N), the groups compared (Groups), the aversion index obtained (AI%) and the P value if significant (*if p < 0.05; **if p < 0.01; ***if p < 0.001).